DMRA insider transaction filings
Damora Therapeutics, Inc. — 9 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-13. Screen DMRA transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-13 | 4 | Cheng Andrew — Director | Grant/award (A): 30,350 (derivative) @ $0 | EDGAR |
| 2026-07-07 | 4 | Winslow Garrett — General Counsel | Option exercise (M): 680 · Sale (S): 245 @ $29.98 · Option exercise (M): 680 (derivative) @ $0 | EDGAR |
| 2026-04-01 | 4 | Jarrett Jennifer — See Remarks, Director | Grant/award (A): 500,000 @ $0 · Grant/award (A): 1,500,000 (derivative) @ $0 | EDGAR |
| 2026-03-25 | 4 | Winslow Garrett — General Counsel | Grant/award (A): 250,000 (derivative) @ $0 | EDGAR |
| 2026-03-25 | 4 | CAIN CHRISTOPHER W. — Director | Grant/award (A): 37,313 (derivative) @ $0 | EDGAR |
| 2026-03-25 | 4 | Bruno Julianne — Director | Grant/award (A): 37,313 (derivative) @ $0 | EDGAR |
| 2026-03-25 | 4 | Turtle Cameron — Director | Grant/award (A): 37,313 (derivative) @ $0 | EDGAR |
| 2026-03-25 | 4 | Fairmount Funds Management LLC — Director, 10% owner Fairmount Healthcare Fund II L.P. — Director, 10% owner Fairmount Healthcare Co-Invest V L.P. — Director, 10% owner Kiselak Tomas — 10% owner Harwin Peter Evan — Director, 10% owner | Grant/award (A): 37,313 (derivative) @ $0 | EDGAR |
| 2026-03-25 | 4 | Landsittel Michael — Director | Grant/award (A): 37,313 (derivative) @ $0 | EDGAR |
Recent 8-K events — Damora Therapeutics, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-07-20 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.03 — Material Modification to Rights of Security Holders 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-17 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-04 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-20 | 8-K | 4.01 — Changes in Registrant's Certifying Accountant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-23 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-10 | 8-K | 2.02 — Results of Operations and Financial Condition 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-11 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-10 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-12 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-06 | 8-K | 3.02 — Unregistered Sales of Equity Securities 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=DMRA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →